Lexaria Bioscience Corp. Common Stock (LEXX)
Stock · NASDAQ · Health Care
$2.94as of 10/16/2026
Price chart
Active signals
LEXX Signal Track Record
How signals performed across all stocks →What LEXX's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Volume Spike | 47 | -3.5% | 47% | August 27, 2026 |
| Bollinger Band Breakout | 28 | -4.9% | 46% | July 17, 2026 |
| Bollinger Band Breakdown | 16 | -10.2% | 38% | September 9, 2026 |
| 200-Day Moving Average TouchActive now | 7 | +3.7% | 57% | April 22, 2026 |
| Any 20-session window (baseline) | -1.4% | 47% |
Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About LEXX
Lexaria Bioscience Corp. operates as a biotechnology company. The company offers its patented drug delivery-enabling platform technology, DehydraTECH, which combines active pharmaceutical ingredients (APIs) with specific long-chain fatty acid-rich triglyceride oils and carrier compounds that improve the way they enter the bloodstream, increasing their effectiveness and allowing for lower overall dosing for improved t…
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Employees
- 7
- Website
- www.lexariabioscience.com/
Fundamentals
- 1-day range
- $2.97$3.19
- Market cap
- $8.82M
- P/E (trailing)
- —
- P/E (forward)
- -7.64
- EPS (trailing)
- $-3.35
- Dividend yield
- —
- Beta
- 0.63
- Avg. volume
- 70.2K
- Dividend pay date
- January 12, 2021
How Lexaria Bioscience Corp. Common Stock Makes Money
Where the revenue actually goes — FY2025 annual results
Source: 10-K filed Nov 28, 2025 · via SEC EDGAR / Finnhub
Forecasts
1 analyst ratings
Lexaria Bioscience Corp. Common Stock Competitors
Chosen by industry and closest market cap.
- LEXXLexaria Bioscience Corp. Common Stock$2.86▼ 4.35%Market cap $8.82MP/E —$2.43$21.6
- IMRNImmuron Limited American Depositary Shares$0.982▼ 4.66%Market cap $8.88MP/E —$0.026$0.098
- XCURExicure Inc. Common Stock$1.12▲ 0.00%Market cap $8.60MP/E —$0.936$9.48
- ASBPAspire Biopharma Holdings Inc. Common Stock$8.78▲ 1.62%Market cap $9.14MP/E —$3.31$562.8
- QNRXQuoin Pharmaceuticals Ltd. American Depositary Shares$3.9▼ 3.23%Market cap $9.18MP/E —$3.25$23.5
- KAPAKairos Pharma Ltd. Common Stock$0.601▼ 10.43%Market cap $8.35MP/E —$0.7108$9.17
- SNGXSoligenix Inc. Common Stock$0.35▼ 2.78%Market cap $8.24MP/E —$0.28$1.76
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| LEXX Lexaria Bioscience Corp. Common Stock | $8.82M | — | $2.86 | ▼ 4.35% | $2.43$21.6 |
| IMRN Immuron Limited American Depositary Shares | $8.88M | — | $0.982 | ▼ 4.66% | $0.026$0.098 |
| XCUR Exicure Inc. Common Stock | $8.60M | — | $1.12 | ▲ 0.00% | $0.936$9.48 |
| ASBP Aspire Biopharma Holdings Inc. Common Stock | $9.14M | — | $8.78 | ▲ 1.62% | $3.31$562.8 |
| QNRX Quoin Pharmaceuticals Ltd. American Depositary Shares | $9.18M | — | $3.9 | ▼ 3.23% | $3.25$23.5 |
| KAPA Kairos Pharma Ltd. Common Stock | $8.35M | — | $0.601 | ▼ 10.43% | $0.7108$9.17 |
| SNGX Soligenix Inc. Common Stock | $8.24M | — | $0.35 | ▼ 2.78% | $0.28$1.76 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- Lexaria Bioscience Announces Results From Animal Study GLP-1-A26-1 Evaluating Both DehydraTECH-CBD Compositions And DehydraTECH-Semaglutide; Unfortunately, The DHT-SEMA Concentrations In Brain Tissue Were All At Levels Below The Lower Limit Of Quantitation Of The Bioassay Utilized In This Studybenzinga · 10/15/2026
- 12 Health Care Stocks Moving In Wednesday's After-Market SessionBenzinga · 10/7/2026
- GLP-1 Weight-Loss/Diabetes Industries Continue Transition to Oral MedicationsYahoo · 10/6/2026
- 12 Health Care Stocks Moving In Thursday's After-Market SessionBenzinga · 9/24/2026
- Lexaria Updates Financial PositionYahoo · 9/17/2026
- 12 Health Care Stocks Moving In Monday's After-Market SessionBenzinga · 9/14/2026
- 12 Health Care Stocks Moving In Monday's Intraday SessionBenzinga · 9/14/2026
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 29, 2026
Lexaria (LEXX) among health care stocks moving after‑market
Lexaria Bioscience appeared in a recent Benzinga roundup of twelve health‑care stocks that showed price movement in Thursday’s after‑market session. The mention highlights that the stock experienced notable activity outside regular trading hours. With the RSI around the mid‑30s, the move comes while the price is near its identified support level of $0.69.
Lexaria (LEXX) among health care stocks moving after‑market. Lexaria Bioscience appeared in a recent Benzinga roundup of twelve health‑care stocks that showed price movement in Thursday’s after‑market session. The mention highlights that the stock experienced notable activity outside regular trading hours. With the RSI around the mid‑30s, the move comes while the price is near its identified support level of $0.69.